NASDAQ:ABMD - ABIOMED Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $333.11 -4.75 (-1.41 %) (As of 11/13/2018 02:48 PM ET)Previous Close$337.86Today's Range$332.6250 - $351.3552-Week Range$186.72 - $459.75Volume455,097 shsAverage Volume693,915 shsMarket Capitalization$18.25 billionP/E Ratio135.96Dividend YieldN/ABeta0.35 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings ABIOMED (NASDAQ:ABMD) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.8 Wall Street analysts have issued ratings and price targets for ABIOMED in the last 12 months. Their average twelve-month price target is $396.00, suggesting that the stock has a possible upside of 18.88%. The high price target for ABMD is $496.00 and the low price target for ABMD is $280.00. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.882.752.752.78Ratings Breakdown: 0 Sell Rating(s)1 Hold Rating(s)7 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)7 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $396.00$374.00$363.1429$323.1429Price Target Upside: 18.88% upside1.76% upside17.14% downside3.70% downsideABIOMED (NASDAQ:ABMD) Consensus Price Target History ABIOMED (NASDAQ:ABMD) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails11/7/2018Morgan StanleyUpgradeEqual ➝ Weight$396.00 ➝ $496.00Medium11/2/2018BTIG ResearchUpgradeNeutral ➝ Buy$450.00Low6/22/2018Piper Jaffray CompaniesBoost Price TargetOverweight$360.00 ➝ $480.00High5/29/2018Jefferies Financial GroupBoost Price TargetBuy$460.00Medium4/4/2018Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$332.00Medium2/16/2018SunTrust BanksReiterated RatingBuy$370.00N/A2/2/2018Leerink SwannBoost Price TargetOutperform$300.00Low2/2/2018GuggenheimReiterated RatingBuy$280.00Medium6/8/2017William BlairReiterated RatingOutperform ➝ OutperformLow(Data available from 11/13/2016 forward) This page was last updated on 11/13/2018 by MarketBeat.com StaffFeatured Article: Do Tariffs Work?